ClinicalTrials.Veeva

Menu
P

P3 Research | Wellington, New Zealand

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TD-4208
AQX-1125
Tanezumab
BBT-401-1S
BTX 1204
QL-007
RTB101
Upadacitinib
MS1819-SD
PT005

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 14 total trials

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and fa...

Enrolling
Alopecia Areata
Drug: Upadacitinib
Drug: Placebo

Phase 2 study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD emphysema

Enrolling
Emphysema
Alpha 1-Antitrypsin Deficiency
Drug: Zemaira
Drug: INBRX-101

Trial sponsors

Mylan logo
AbbVie logo
A
A
B
Bridge Biotherapeutics logo
I
P
Pfizer logo
Q

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems